Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Immuneering Corp (NASDAQ: IMRX) was $6.28 for the day, up 3.80% from the previous closing price of $6.05. In other words, the price has increased by $3.80 from its previous closing price. On the day, 2.26 million shares were traded. IMRX stock price reached its highest trading level at $6.6 during the session, while it also had its lowest trading level at $6.1.
Ratios:
Our analysis of IMRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.70 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 15, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $20 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 01 ’25 when Morales Mallory bought 300 shares for $6.39 per share. The transaction valued at 1,917 led to the insider holds 27,533 shares of the business.
Neufeld Leah R bought 800 shares of IMRX for $5,103 on Oct 01 ’25. The CHIEF PEOPLE OFFICER now owns 23,344 shares after completing the transaction at $6.38 per share. On Oct 01 ’25, another insider, Bookman Michael, who serves as the CHIEF LEGAL OFFICER, SECRETARY of the company, bought 1,020 shares for $6.83 each. As a result, the insider paid 6,966 and bolstered with 4,870 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 397139040 and an Enterprise Value of 205727616.
Stock Price History:
The Beta on a monthly basis for IMRX is 0.48, which has changed by 1.627615 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, IMRX has reached a high of $10.08, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 10.45%, while the 200-Day Moving Average is calculated to be 111.73%.
Shares Statistics:
IMRX traded an average of 1.61M shares per day over the past three months and 5907800 shares per day over the past ten days. A total of 60.53M shares are outstanding, with a floating share count of 36.20M. Insiders hold about 28.45% of the company’s shares, while institutions hold 6.33% stake in the company. Shares short for IMRX as of 1757894400 were 2958155 with a Short Ratio of 1.84, compared to 1755216000 on 1581442. Therefore, it implies a Short% of Shares Outstanding of 2958155 and a Short% of Float of 8.9499995.
Earnings Estimates
Immuneering Corp (IMRX) is currently under the scrutiny of 5.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.22 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.3 and -$1.89 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.9, with 5.0 analysts recommending between -$1.34 and -$2.28.
